<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6091236</article-id><article-id pub-id-type="doi">10.3389/fmicb.2018.01658</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Molecular Cloning and Docking of <italic>speB</italic> Gene Encoding Cysteine Protease With Antibiotic Interaction in <italic>Streptococcus pyogenes</italic> NBMKU12 From the Clinical Isolates</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Balasubramanian</surname><given-names>Natesan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/105608/overview"/></contrib><contrib contrib-type="author"><name><surname>Varatharaju</surname><given-names>Govintharaj</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shanmugaiah</surname><given-names>Vellasamy</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Balakrishnan</surname><given-names>Karuppiah</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thirunarayan</surname><given-names>Mandayam A.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Immunology, School of Biological Sciences, Madurai Kamaraj University</institution>, <addr-line>Madurai</addr-line>, <country>India</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Microbial Technology, School of Biological Sciences, Madurai Kamaraj University</institution>, <addr-line>Madurai</addr-line>, <country>India</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Microbiology, Apollo Hospitals</institution>, <addr-line>Chennai</addr-line>, <country>India</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Farhat Afrin, Taibah University, Saudi Arabia</p></fn><fn fn-type="edited-by"><p>Reviewed by: Ravi Kasiappan, Central Food Technological Research Institute (CSIR), India; Gomathinayagam Subramanian, University of Guyana, Guyana</p></fn><corresp id="c001">*Correspondence: Natesan Balasubramanian, <email>yenbala2007@gmail.com</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn></author-notes><pub-date pub-type="epub"><day>07</day><month>8</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>1658</elocation-id><history><date date-type="received"><day>23</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>03</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#169; 2018 Balasubramanian, Varatharaju, Shanmugaiah, Balakrishnan and Thirunarayan.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Balasubramanian, Varatharaju, Shanmugaiah, Balakrishnan and Thirunarayan</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><italic>Streptococcus pyogenes</italic> causes a variety of diseases ranging from mild diseases to severe invasive infections which result in significant morbidity and mortality. This study focuses on the antibiotic resistance of <italic>S. pyogenes</italic> and their interaction with cysteine protease. Around 36 beta-hemolytic isolates were collected from the clinical lab, of which seven isolates (19.4%) were identified as <italic>Streptococcus pyogenes</italic>. One of the seven isolates was collected from a urinary tract infection, which was identified by antibody agglutination and MALTI-TOF-MS, and it is designated as <italic>S. pyogenes</italic> NBMKU12. Around 8.3 to 66.6 % of the isolates were found to be resistant to one or more antimicrobial agents, especially, penicillin-G resistance was exhibited by 29.1% of the isolates. In the NBMKU12 isolate, the beta lactem (<italic>TEM</italic>) gene was detected among the 13 antibiotic genes for which it was tested. Furthermore, when analysis for presence of 13 virulence genes were carried out in NBMKU12 isolate, only <italic>speJ</italic> and <italic>speB</italic> were detected. The <italic>speB</italic> (streptococcal pyrogenic exotoxin B) encoding cysteine protease gene was cloned. This was followed by performing DNA sequencing to understand the putative cysteine protease interaction with antibiotics, inhibitors, and substrate. The <italic>speB</italic> gene consists of 1197 nucleotides and encodes a protein with multiple domains, including a signal peptide (aa 1&#8211;22), an inhibitor region (aa 27&#8211;156), and a catalytic cysteine domain (aa 160&#8211;367). The signal peptide cleavage site is predicted between Ala22 and Asn23. The putative 398 amino acid residues were found to have a theoretical pI of 8.76 and a molecular mass of 43,204.36 Da. The tested culture supernatants of NBMKU12 isolate exhibited the proteolytic activity against casein, papaya and pineapple used as substrates. The proteolytic activity suggests the expression of speB gene. Molecular docking analysis of cysteine protease showed that erythromycin (bond length 2.41 &#197;), followed by chloramphenicol (2.51 &#197;), exhibited a strong interaction; while penicillin-G (3.24 &#197;) exhibited a weak interaction, and this factor could be considered as a cause for penicillin-G resistance. The present study contributes to a better understanding of <italic>speB</italic> gene encoding cysteine protease, antibiotic resistance, and their interaction in the isolate, <italic>S. pyogenes</italic> NBMKU12. The antibiotics and cysteine protease interaction study confirms the resistance or sensitivity of <italic>S. pyogenes</italic>. Hence, it could be hypothesized that the isolate NBMKU12 is resistant to most of the tested antibiotics, and this resistance might be a cause for mutation.</p></abstract><kwd-group><kwd>antibiotic resistance</kwd><kwd>gene cloning</kwd><kwd>cysteine protease</kwd><kwd><italic>Streptococcus pyogenes</italic></kwd><kwd>virulence factors</kwd><kwd>docking analysis</kwd></kwd-group><counts><fig-count count="7"/><table-count count="4"/><equation-count count="0"/><ref-count count="68"/><page-count count="13"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p><italic>Streptococcus pyogenes</italic> (Group A Streptococci) is the most widespread pathogenic bacteria that infects children and adolescents (<xref rid="B8" ref-type="bibr">Brook and Dohar, 2006</xref>). It causes a wide range of infections from pharyngitis to severe systemic diseases, such as necrotizing fasciitis or streptococcal toxic shock syndrome (STSS), and post-infection complications (<xref rid="B17" ref-type="bibr">Cunningham, 2000</xref>; <xref rid="B50" ref-type="bibr">Pires et al., 2012</xref>). Moreover, <italic>S. pyogenes</italic> causes extensive cutaneous infections ranging from superficial cellulitis to severe cellulitis, and even life-threatening pyoderma (<xref rid="B61" ref-type="bibr">Sumitomo et al., 2018</xref>). Group A streptococci (GAS) phage-associated pyrogenic exotoxins or superantigens (<xref rid="B30" ref-type="bibr">Jing et al., 2006</xref>) have been shown to cause severe diseases such as scarlet fever, rheumatic fever, and rheumatic heart diseases (<xref rid="B52" ref-type="bibr">Rato et al., 2010</xref>).</p><p>Most of the <italic>S. pyogenes</italic> strains are susceptible to penicillin (<xref rid="B5" ref-type="bibr">Bassetti et al., 2000</xref>), and hence penicillin is universally recommended for treatment of <italic>S. pyogenes</italic> infections (<xref rid="B7" ref-type="bibr">Bowen et al., 2012</xref>). However, macrolides are used as an alternative in penicillin-allergic patients (<xref rid="B10" ref-type="bibr">Camara et al., 2013</xref>). Further, increased macrolide-resistance and asymptomatic oropharyngeal colonization of <italic>S. pyogenes</italic> have been reported in different countries (<xref rid="B24" ref-type="bibr">Felmingham et al., 2004</xref>; <xref rid="B13" ref-type="bibr">Chang et al., 2010</xref>). In recent years, an increase of up to 50% in streptococci resistance to penicillin has been observed (<xref rid="B42" ref-type="bibr">Nunes et al., 2005</xref>). Recent surveillance studies have shown temporal changes in drug-resistant streptococci, predominantly due to environmental factors, and this could be a major reason for drug-resistant strains causing pediatric and adult diseases (<xref rid="B42" ref-type="bibr">Nunes et al., 2005</xref>; <xref rid="B10" ref-type="bibr">Camara et al., 2013</xref>).</p><p><italic>Streptococcus pyogenes</italic> are primarily identified using the antibiotic bacitracin to which it is susceptible. This acts as the factor for differentiating beta-hemolytic streptococci in human infections (<xref rid="B23" ref-type="bibr">Facklam, 2002</xref>). However, recently isolated clinical isolates are found to be resistant to bacitracin (<xref rid="B46" ref-type="bibr">Perez-Trallero et al., 2007</xref>). Keeping the important development of streptococcal resistance in mind, we have studied the collection of human isolates of <italic>S. pyogenes</italic> for their genetic determinants of resistance to ampicillin, penicillin-G, tetracycline, chloramphenicol, and vancomycin. The present research work has been carried out to understand the antibiotic resistance mechanism in the NBMKU12 isolate and its putative cysteine protease interaction with selected antibiotics, substrates, and inhibitors. These interaction studies provide vital data concerning virulence genotypes and antibiotic resistance genes of the novel isolate of NBMKU12.</p><p>Cysteine proteases consist of 108 different families (<xref rid="B54" ref-type="bibr">Rawlings et al., 2012</xref>), and the catalytic residues are present either in the Cys-His or His-Cys order (<xref rid="B55" ref-type="bibr">Richter et al., 2012</xref>). In cysteine proteases, the Cys residue acts as the nucleophile agent and the His residue acts as the proton shuttling residue (<xref rid="B16" ref-type="bibr">Cstorer and Menard, 1994</xref>). Cysteine proteases are responsible for several biological processes, including degradation of peptides and proteins (<xref rid="B27" ref-type="bibr">Grzonka et al., 2001</xref>). Active <italic>speB</italic> encoding cysteine protease cleaves the host extracellular matrix (<xref rid="B31" ref-type="bibr">Kapur et al., 1993</xref>), immunoglobulins (<xref rid="B22" ref-type="bibr">Eriksson and Norgren, 2003</xref>), and complementary components (<xref rid="B63" ref-type="bibr">Terao et al., 2008</xref>). In addition, the cysteine protease has the ability to cleave host proteins (<xref rid="B66" ref-type="bibr">Walker et al., 2007</xref>), and this proteolytic activity contributes to the bacterial evasion from the host defense system and systemic dissemination (<xref rid="B40" ref-type="bibr">Nelson et al., 2011</xref>). Immunoglobulin G-degrading enzyme and <italic>speB</italic> encoding cysteine protease are the two major cysteine proteases which are secreted by Group A streptococcus (GAS) and involved in host immune suppression (<xref rid="B62" ref-type="bibr">Sumitomo et al., 2013</xref>).</p><p>The present study also tested the cysteine protease activity in the isolate NBMKU12, using different substrates, to confirm its degradation ability. Here we present the process of <italic>speB</italic> gene detection, its molecular characterization, and putative cysteine protease interaction with antibiotics, inhibitors, and substrate to understand the S. <italic>pyogenes</italic> pathogenesis through a UTI isolate NBMKU12.</p></sec><sec sec-type="materials|methods" id="s1"><title>Materials and Methods</title><sec><title>Bacteria Collection and Identification</title><p>A total of 36 beta-hemolytic isolates (I-batch) were collected from the Microbiology Laboratory, Apollo Hospitals, Chennai, India. These 36 isolates were isolated from patients receiving medical care in the Apollo Hospitals. The isolates were collected from samples of urine (20), secretions (7), blood (3), and other sources (6). Among the 36 isolates, 7 isolates of <italic>Streptococcus pyogenes</italic>, and 1 isolate of NBMKU12 collected from a patient with urinary tract infection (UTI), were used in this study. The collected isolates were purified and stored at -80&#176;C in sterilized Todd-Hewitt broth with 20% glycerol. The isolates, including NBMKU12, were identified by colony morphology on sheep-blood agar using beta-hemolysis, group A-specific antiserum HiStrep Latex Agglutination Test (HiMedia, India), and MALDI-TOF-MS.</p></sec><sec><title>MALDI-TOF-MS Analysis</title><p>The identification of streptococcus by MALDI-TOF-MS system (VITEK MS, BioM&#233;rieux, France) was carried out as described earlier (<xref rid="B33" ref-type="bibr">Lartigue et al., 2009</xref>). In brief, overnight NBMKU12 fresh colonies were picked from a solid culture, mixed with a CHCA matrix on a conductive target slide, and inserted into the VITEK MS system for performing a rapid automated identification. An <italic>E. coli</italic> calibrator was used for the validation of the similarity analysis. Only those identifications with a score of 99.9% were considered, although a score of &gt;70% was considered acceptable. Identification is based on the signature mass spectrum of each organism that is generated. It was then compared with a validated database of spectra for a range of pathogens. All the spectra were analyzed using a MALDI V3 software package that compares the experimental data with the reference spectra and provides identification.</p></sec><sec><title>Culture Media, Bacterial Growth, and Storage Condition</title><p>The solid growth medium was used for culture and colony isolation in Todd-Hewitt Agar, or Colombia agar supplemented with 5% (v/v) sheep blood (HiMedia, India). Liquid cultures were grown in Todd-Hewitt broth supplemented with 1% (w/v) yeast extract, Tryptic Soy broth (HiMedia, India), and incubated at 37&#176; C for 16&#8211;18 h. The late exponential phase culture was mixed with 20% sterilized glycerol and maintained at -80&#176;C for further use.</p></sec><sec><title>MIC Test</title><p>MIC test was done in E strip on Mueller-Hinton agar with 5% (v/v) sheep blood (HiMedia, India). The plates were incubated for 20&#8211;24 h at 37&#176; C. An antibiotic susceptibility test was performed according to the Clinical Laboratory&#8217;s Standards Institute (CLSI) guidelines for ampicillin, vancomycin, ceftriaxone, amoxiclav, and chloramphenicol (HiMedia, India).</p></sec><sec><title>Antibiotic Susceptibility Test</title><p>Antibiotic susceptibility tests were performed for all isolates of <italic>S. pyogenes</italic> by disk diffusion method. A fresh colony was inoculated in 2 mL of Todd-Hewitt broth with 1% yeast extract and incubated at 37&#176;C for 18&#8211;20 h. A 100 &#956;L liquid culture of each isolate was swabbed using sterilized cotton buds on Muller-Hinton agar with 5% sheep blood (HiMedia, India). After the <italic>S. pyogenes</italic> was swabbed, antibiotic disks were placed on the medium. Antibiotic susceptibility was tested against ampicillin (10 mcg/mL), penicillin-G (10 mcg/mL), tetracycline (30 mcg/mL), erythromycin (15 mcg/mL), azithromycin (30 mcg/mL), vancomycin (30 mcg/mL), ceftriaxone (30 mcg/mL), amoxiclav (30 mcg/mL), and chloramphenicol (10 mcg/mL). The plates were incubated at 37&#176;C for 20&#8211;24 h. The zone of inhibition was measured, and the results were interpreted according to the Clinical Laboratory&#8217;s Standards Institute guidelines (<xref rid="B14" ref-type="bibr">CLSI, 2006</xref>).</p></sec><sec><title>Genomic DNA Extraction</title><p>The Genomic DNA was isolated using HiPurA bacterial genomic DNA purification kit (HiMedia, India) with slight modifications. Briefly, bacterial cells were grown in 5 mL Todd-Hewitt broth supplemented with 1% yeast extract (w/v) (HiMedia, India), and incubated at 37&#176;C for 16&#8211;18 h. The culture was centrifuged at 12000 rpm for 2 min, and the pellet was resuspended in 200 &#956;L lysozyme solution (45 mg/mL). It was then incubated for 30 min at 37&#176;C, followed by the addition of 20 &#956;L Proteinase K (20 mg/mL) and 20 &#956;L RNase mixture, and again incubated at room temperature. Finally, the DNA was eluted with 150 &#956;L of Elution buffer and stored at -20&#176;C or immediately used for polymerase chain reaction (PCR).</p></sec><sec><title>Detection of Virulence Genes in <italic>S. pyogenes</italic></title><p>To check the presence of erythrogenic exotoxins or superantigens in NBMKU12 isolate, the PCR reaction was carried out in single and multiplex formats with specific primers. The PCR reaction was performed for several genes (<italic>speK, speL, speC, speM, speJ, speH, speA, slA, prtF1, speI, spd1, sdn</italic>, and <italic>speB</italic>), and those samples lacking DNA were used as negative controls. The primer sequence of different genes, their amplification length, and gene description are elucidated in <bold>Table <xref rid="T1" ref-type="table">1</xref></bold>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Detection of virulence genes primers used in PCR reaction.</p></caption></table-wrap></sec><sec><title>Detection of Antibiotic Genes in <italic>S. pyogenes</italic></title><p>To check the presence of antibiotic resistant (genotypes) genes in NBMKU12 isolate, amplification was performed in a single or multiplex PCR with specific primers. The presence of macrolide resistant genes <italic>mef(A)</italic>, tetracycline resistant genes <italic>tet(M), tet(O), tet(Q), tet(T)</italic>, beta-lactam resistant genes <italic>oxa, tem</italic>, chloramphenicol resistant genes <italic>cat1, cmLA</italic>, ampicillin resistant genes <italic>mox1, dha1</italic>, and penicillin resistant genes <italic>pbp1a</italic> and <italic>pbp2b</italic> were tested either by single or multiplex PCR as described in <bold>Table <xref rid="T2" ref-type="table">2</xref></bold>.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Detection of antibiotic resistance genes primers used in PCR reaction.</p></caption></table-wrap></sec><sec><title>Plate Assay for Lytic Activity in <italic>S. pyogenes</italic></title><p>Cysteine protease activity of <italic>S. pyogenes</italic> NBMKU12 isolate was evaluated by standard casein, papaya, and pineapple (bromelain) hydrolysis with slight modifications (<xref rid="B44" ref-type="bibr">Olsen et al., 2015</xref>). Briefly, the isolate NBMKU12 was taken from cryopreserved stocks and inoculated on Columbia agar supplemented with 5% sheep blood (HiMedia, India), and then incubated at 37&#176;C for 24 h. Fresh colonies of NBMKU12 isolate were subcultured for 18&#8211;20 h in the early stationary growth phase in Todd-Hewitt broth supplemented with 0.5% yeast extract. A 1.25 mL of early stationary growth culture (5%) was inoculated in 25 mL Todd-Hewitt broth supplemented with 0.5% yeast extract and incubated at 37&#176;C for 24&#8211;48 h. The culture was centrifuged and filtered (0.22 &#956;m, HiMedia, India), and then concentrated by lyophilization (Alpha 1-2 LDPlus, Vacuubrand GMBH, Germany). A 200 &#956;L of the concentrated supernatant was added on 1% casein agar, papaya agar, and pineapple agar well plates. The plates were incubated for 24 h at 37&#176;C in an aerobic chamber (Hemco Equipment, India). The digested plates were stained using 1% Congo red staining and further steps followed by <xref rid="B3" ref-type="bibr">Balasubramanian et al. (2012a)</xref>. Activities of the secreted cysteine protease were studied by measuring the zone of casein, papaya, and pineapple lyses around each well, using a standard ruler scale.</p></sec><sec><title><italic>speB</italic> Gene Cloning and Sequence Analysis</title><p>Based on the <italic>speB</italic> gene sequence available in the GenBank database (NCBI), the specific primers <italic>speB</italic>-F (5&#8242;-ATGAATAAAAAGAAATTAGGTGTCAG-3&#8242;) and <italic>speB</italic>-R (5&#8242;-CTAAGGTTTGATGCCTACAA-3) were designed to amplify the full length gene. The PCR reactions were performed in the following conditions: 95&#176;C for 5 min, followed by 35 cycles at 95&#176;C for 30 s, 45&#176;C for 60 s, and 72&#176;C for 30 s, and a final extension at 72&#176;C for 7 min. The PCR amplification was confirmed by agarose gel electrophoresis (1%), the amplicon cloned in pCR4-TOPO vector (Invitrogen, Germany) and transformed into TOP10 cells by the heat shock method. The DNA insert were conformed by PCR. The DNA was isolated (HiMedia, India) from positive clones, and then sequenced (Macrogen, South Korea). The full-length DNA was obtained by joining the two fragments using the Bio-Edit Program.</p></sec><sec><title>Bioinformatics Analysis</title><p>Cysteine protein motifs were analyzed using the following programs: Simple Modular Architecture Research Tool (SMART)<sup><xref ref-type="fn" rid="fn01">1</xref></sup>, Conserved Domain search from NCBI-CD<sup><xref ref-type="fn" rid="fn02">2</xref></sup>, signal peptide from Signal lP<sup><xref ref-type="fn" rid="fn03">3</xref></sup>, and prediction of non-classical protein secretion-SecretomeP<sup><xref ref-type="fn" rid="fn04">4</xref></sup>. The physico-chemical properties were determined from ProtParam using the ExPASy tool<sup><xref ref-type="fn" rid="fn05">5</xref></sup>. The sequence similarities were determined from NCBI-BLAST<sup><xref ref-type="fn" rid="fn06">6</xref></sup>, and a multiple sequence alignment was determined using CLUSTAL Win BioEdit 7.0.</p></sec><sec><title><italic>In silico</italic> Analysis</title><p>The gene sequence encodes for cysteine protease were used for the prediction of 3-dimensional protein structures [3D] by homology modeling using MODELLER 9v7 (<xref rid="B56" ref-type="bibr">Sali and Blundell, 1993</xref>). The constructed tertiary structure was validated for quality, with the help of online servers such as PROCHECK (<xref rid="B34" ref-type="bibr">Laskowaski et al., 1993</xref>), PROSA (<xref rid="B68" ref-type="bibr">Wiederstein and Sippl, 2007</xref>), and VERIFY-3D (<xref rid="B21" ref-type="bibr">Eisenberg et al., 1997</xref>). The validated model was studied for the interaction of cysteine protease with different antibiotics, inhibitors, and substrate, by using AutoDock4.0 (<xref rid="B37" ref-type="bibr">Morris et al., 2009</xref>) and Patchdock (<xref rid="B57" ref-type="bibr">Schneidman-Duhovny et al., 2005</xref>). Visualization of the 3D structure and the study of interaction profiles were carried out with the help of Pymol<sup><xref ref-type="fn" rid="fn07">7</xref></sup> and Ligplot (<xref rid="B67" ref-type="bibr">Wallace et al., 1995</xref>).</p></sec><sec><title>Secondary Structure Analysis</title><p>The secondary structure of cysteine protease was analyzed the Self-Optimized Prediction Method Program (SOPMA) (<xref rid="B26" ref-type="bibr">Geourjon and Del&#233;age, 1995</xref>), and its physico-chemical properties were analyzed using ProtParam (<xref rid="B25" ref-type="bibr">Gasteiger et al., 2005</xref>).</p></sec><sec><title>Homology Modeling of Cysteine Protease</title><p>The suitable template sequence for cysteine protease structure prediction was identified by BLAST program and retrieved from the PDB. The crystal structure of the mature streptococcal Cysteine protease, mSpeB, was used as a template (PDBID: 2UZJ) (<xref rid="B43" ref-type="bibr">Olsen et al., 2009</xref>) with a resolution of 1.55 &#197;. Homology modeling of the cysteine protease was performed using MODELLER 9v7. The model that was constructed with a low molecular objective function (MOF) value was selected and used for docking studies.</p></sec><sec><title>Molecular Docking</title><p>The selected 3D models of cysteine protease, antibiotics, inhibitors, and substrate were prepared for molecular docking using the AutoDock tool. Auto Grid (<xref rid="B68" ref-type="bibr">Wiederstein and Sippl, 2007</xref>) was used to define the active site. A 41_43_45 points were set as the grid size, with a grid spacing of 0.385 &#197;. The docked conformation with a low binding energy was selected for further analysis.</p></sec></sec><sec><title>Results</title><sec><title>Bacterial Identification by HiStrep Latex Agglutination and MALTI-TOF-MS</title><p>A clinical isolate of NBMKU12 showed clear hemolysis on sheep blood agar and, after further testing with an antiserum grouping HiStrep Latex kit, confirmed agglutination for GAS. In addition, the isolate NBMKU12 suspected of being GAS was identified using MALDI-TOF-MS with m/z score 99.9%. After identification, this strain was labeled as <italic>Streptococcus pyogenes</italic> NBMKU12.</p></sec><sec><title>MIC Test</title><p>Based on the CLSI recommendations, the MIC test was carried out for NBMKU12 isolate. The MIC analysis showed antibiotic susceptibilities to ampicillin (0.25 mcg/mL), chloramphenicol (4 mcg/mL), ceftriaxone (1.5 mcg/mL), clavulanic acid (2.5 mcg/mL), and vancomycin (1 mcg/mL). The antibiotic concentrations in the disks were selected based on the CLSI and other published literature information.</p></sec><sec><title>Antibiotic Susceptibility Test</title><p>Out of the seven <italic>S. pyogenes</italic> isolates, 25.3% were found to be resistant to multiple antimicrobial agents. The resistance to other antibiotics were observed as follows: ampicillin 71.4%, ceftriaxone 57.1%, and penicillin-G 42.8%. No resistance was observed for the antibiotics amoxiclav, azithromycin, and erythromycin (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Antibiotics susceptibility test in <italic>Streptococcus pyogenes</italic> NBMKU12 isolate. Pen, penicillin; amp, ampicillin; cef, ceftriaxone; chl, chloramphenicol; van, vancomycin; ama, amoxiclav; tet, tetracycline; ery, erythromycin; azy, azithromycin.</p></caption><graphic xlink:href="fmicb-09-01658-g001"/></fig></sec><sec><title>Detection of Virulence Genes in <italic>S. pyogenes</italic></title><p>We screened the isolate NBMKU12 for 13 bacteriophage-associated virulence genes, either pyrogenic exotoxins or superantigens. The screening resulted in the identification of two pyrogenic exotoxin genes, <italic>speJ</italic> and <italic>speB</italic> (<bold>Figure <xref ref-type="fig" rid="F2">2</xref></bold>). Of these two, we selected the <italic>speB</italic> gene for further molecular characterization and to encode for a cysteine protease that is involved in host immune suppression.</p><fig id="F2" position="float"><label>FIGURE 2</label><caption><p>Virulence genes detection in <italic>Streptococcus pyogenes</italic> NBMKU12 isolate. M, Marker DNA (100 bp DNA Ladder H3 RTU, GeneDireX), speB amplification (1.2 kb), speJ (535 bp).</p></caption><graphic xlink:href="fmicb-09-01658-g002"/></fig></sec><sec><title>Detection of Antibiotic Genes in <italic>S. pyogenes</italic></title><p>To understand the antibiotic resistance genotype in NBMKU12 isolate, we performed the PCR reaction for 13 antibiotic genes [<italic>mef</italic>(<italic>A</italic>), <italic>tet</italic>(<italic>M</italic>), <italic>tet</italic>(<italic>O</italic>), <italic>tet</italic>(<italic>Q</italic>), <italic>tet</italic>(<italic>T</italic>), <italic>OXA</italic>, <italic>TEM</italic>, <italic>cat1</italic>, <italic>cmlA, mox1, DHA1, PBP1a</italic>, and PBP<italic>2B</italic>] in a single and multiplex PCR. Among these, the Beta lactam (<italic>TEM</italic>) gene was the only gene that was detected in the NBMKU12 isolate (data not shown).</p></sec><sec><title><italic>speB</italic> Gene Cloning and Sequence Analysis</title><p>The NBMKU12 isolate&#8217;s <italic>speB</italic> gene cloned full length sequence was obtained by joining the forward and reverse sequences. The full-length gene sequence was deposited in the GenBank database, and an accession number was obtained (<ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="MF574208">MF574208</ext-link>). The <italic>speB</italic> gene consists of 1197 nucleotides with an open reading frame (ORF) of 398 amino acid residues. In this cysteine protease, 1&#8211;22 aa is a signal peptide, 22&#8211;23 aa is a cleavage site, and 160&#8211;367 aa is composed of the catalytic domain. The calculated theoretical pI for cysteine protease is 8.76 and the molecular mass is 43.2 kDa.</p><p>The NCBI-BLASTp program revealed that the <italic>speB</italic> putative amino acid sequence of cysteine protease has 99% similarities to <italic>Streptococcus pyogenes</italic> pyrogenic exotoxins B (<italic>speB</italic>), peptidase 10, and streptopain, in different <italic>S. pyogenes</italic> strains as follows<italic>: Streptococcus pyogenes</italic> streptopain (GenBank Accession No. WP_023079791), <italic>Streptococcus pyogenes</italic> streptopain (WP_011285235), <italic>Streptococcus pyogenes</italic> pyrogenic exotoxins B (BAB40954), <italic>Streptococcus pyogenes</italic> pyrogenic exotoxins B (AAA27000), <italic>Streptococcus pyogenes</italic> streptopain (WP_002991253), <italic>Streptococcus pyogenes</italic> streptopain (WP_038433740), <italic>Streptococcus pyogenes</italic> peptidase c10 (WP_009881074), <italic>Streptococcus pyogenes</italic> peptidase c10 (WP_063811911), and <italic>Streptococcus pyogenes</italic> pyrogenic exotoxins B (WP_076639504) (<bold>Figure <xref ref-type="fig" rid="F3">3</xref></bold>).</p><fig id="F3" position="float"><label>FIGURE 3</label><caption><p>Alignment of the amino acid sequence of cysteine protease domain from <italic>Streptococcus pyogenes</italic> NBMKU12, with other cysteine proteases from <italic>Streptococcus pyogenes</italic> (WP_023079791), <italic>Streptococcus pyogenes</italic> (WP_011285235), <italic>Streptococcus pyogenes</italic> (ABX44733), <italic>Streptococcus pyogenes</italic> (WP_023610705), <italic>Streptococcus pseudoporcinus</italic> (WP_077322996), <italic>Streptococcus porcinus</italic> (WP_003083607), <italic>Streptococcus didelphis</italic> (WP_018367158). Areas shaded in dark green followed by light green indicates a high degree of similarity (&gt;80%), and unshaded areas are regions of variability among the proteins.</p></caption><graphic xlink:href="fmicb-09-01658-g003"/></fig></sec><sec><title>Plate Assay for Lytic Activity of <italic>S. pyogenes</italic></title><p>The culture supernatant of <italic>S. pyogenes</italic> NBMKU12 was tested, at different durations of incubation, for lysis on 1% casein, papaya, and pineapple (Bromelain) amended agar. The lysis was read as the extent of the clearing zone around the well on the respective agar plates. This lysis is due to the crude concentrated supernatant of <italic>S. pyogenes</italic> NBMKU12, which varied based on the duration of incubation. A large and prominent lysis zone was observed after 24 and 36 h of incubation (<bold>Figure <xref ref-type="fig" rid="F4">4</xref></bold>). Among the substrates tested, a large lysis zone was observed on the pineapple agar, followed by one on the papaya agar.</p><fig id="F4" position="float"><label>FIGURE 4</label><caption><p>Cysteine protease hydrolytic activity assay in <italic>Streptococcus pyogenes</italic> NBMKU12 isolate. <bold>(A)</bold> Casein agar, <bold>(B)</bold> Papaya agar, <bold>(C)</bold> Pineapple agar (a: 24 h, b: 36 h, c: 48 h incubated culture filtrates).</p></caption><graphic xlink:href="fmicb-09-01658-g004"/></fig></sec><sec><title><italic>In silico</italic> Analysis</title><sec><title>Secondary Structure Analysis</title><p>The cysteine protease secondary structure analysis revealed that 33.67, 34.92, 20.60, and 10.80% amino acid residues are present in the form of a helix, random coil, extended strand, and turns, respectively (<bold>Table <xref rid="T3" ref-type="table">3</xref></bold>). The random coil occupies the largest part of the protein, followed by alpha helix, extended strand, and then beta turns. This clearly indicates that the protein is stable. The PsiPred analysis revealed that the cysteine protease consists of 7 Helices, 11 Strands, and 19 Coils (<bold>Figure <xref ref-type="fig" rid="F5">5</xref></bold>).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Secondary structure analysis by PsiPred and SOPMA tool.</p></caption></table-wrap><fig id="F5" position="float"><label>FIGURE 5</label><caption><p>Predicted structure of cysteine protease shows rainbow colored cartoon representation; Helices, Coil and Strands are labeled.</p></caption><graphic xlink:href="fmicb-09-01658-g005"/></fig></sec><sec><title>Homology Modeling and Validation</title><p>The crystal structure of the mature Streptococcal cysteine protease, mSpeB, was used as a template (PDBID: 2UZJ) with the resolution of 1.55 &#197;. This was selected based on the BLAST result, and the target model (cysteine protease) was built using MODELLER 9v7. Based on the physico-chemical properties of the predicted molecule, the resulting model has four chains (A, B, C, and D) with a molecular weight of 43,204.36 Da and an instability index [II] of 35.20. This classified the protein as a stable protein, and the minimized energy of the molecule was calculated as 79,634.656 kJ/mol.</p><p>The PROCHECK analysis of the cysteine protease model showed that 93% of residues were found in the most favored region, 4.9% residues in the allowed regions, and 1.2% residues in generously allowed regions (<bold>Table <xref rid="T4" ref-type="table">4</xref></bold>), which suggests that the model is of good quality. In addition, the PROSA tool (Supplementary Figures <xref ref-type="supplementary-material" rid="SM1">1a,b</xref>) shows the <italic>Z</italic>-score of the cysteine protease structure to be -8.3, a value that is within the acceptable range. The atomic model&#8217;s (3D) compatibility with its own amino acid sequence (1D) shows a model score of 0.79, which was found to be close to the template score (0.69).</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Stereo-chemical quality of cysteine protease by PROCHECK and model evaluation by PROSA.</p></caption></table-wrap></sec><sec><title>Molecular Docking of Cysteine Protease</title><p>The amino acid residues involved in the active site of the cysteine protease are HGEKVSNYAFQLM. The binding affinities of cysteine protease with penicillin-G (<bold>Figure <xref ref-type="fig" rid="F6">6A</xref></bold>), erythromycin (<bold>Figure <xref ref-type="fig" rid="F6">6B</xref></bold>), azithromycin (<bold>Figure <xref ref-type="fig" rid="F6">6C</xref></bold>), and chloramphenicol (<bold>Figure <xref ref-type="fig" rid="F6">6D</xref></bold>) are -8.8, -14.8, -15.5, and -13.5, respectively (Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1a</xref>). Of these, azithromycin strongly interacts with the receptor in the residue of VAL184 with 2.40 &#197; length, and the docking happens with inhibitors Cystatin A (<bold>Figure <xref ref-type="fig" rid="F7">7A</xref></bold>), Cystatin B (<bold>Figure <xref ref-type="fig" rid="F7">7B</xref></bold>), and Cystatin S (<bold>Figure <xref ref-type="fig" rid="F7">7C</xref></bold> and Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1b</xref>) with the scores of 15194, 18223, and 12115, respectively. Finally, the model was docked with the papain substrate, and the binding score is 17044 (<bold>Figure <xref ref-type="fig" rid="F7">7D</xref></bold> and Supplementary Table <xref ref-type="supplementary-material" rid="SM1">1b</xref>).</p><fig id="F6" position="float"><label>FIGURE 6</label><caption><p>Docked complex showing interactions between cysteine protease with <bold>(A)</bold> Penicillin-G, <bold>(B)</bold> Azithromycin, <bold>(C)</bold> Erythromycin, <bold>(D)</bold> Chloramphenicol.</p></caption><graphic xlink:href="fmicb-09-01658-g006"/></fig><fig id="F7" position="float"><label>FIGURE 7</label><caption><p>Docked complex showing interactions between cysteine protease and inhibitor <bold>(A)</bold> Cystatin A, <bold>(B)</bold> Cystatin C, <bold>(C)</bold> Cystatin S, <bold>(D)</bold> Papain.</p></caption><graphic xlink:href="fmicb-09-01658-g007"/></fig></sec></sec></sec><sec><title>Discussion</title><p>We have used antibody agglutination tests for the identification of streptococcus isolates. Further, the MALTI-TOF-MS has also precisely confirmed that the isolate NBMKU12 belongs to the GAS. Previously, GAS clinical isolates have been identified by MALTI-TOF-MS (<xref rid="B11" ref-type="bibr">Carbonnelle et al., 2011</xref>; <xref rid="B45" ref-type="bibr">Pe&#226;rez-Sancho et al., 2017</xref>), and also group B Streptococcus (GBS) (<xref rid="B6" ref-type="bibr">Binghuai et al., 2014</xref>; <xref rid="B60" ref-type="bibr">Singhai et al., 2015</xref>). The NBMKU12 was isolated from a male patient with a UTI. The streptococcal isolates were characterized by antibiogram assay with nine antibiotics, and the present study focuses on the specific isolate NBMKU12. Antibiogram tests revealed that the isolate NBMKU12 showed 33.3% of resistance. NBMKU12 showed resistance toward ampicillin, penicillin-G, and ceftriaxone, while it showed intermediate resistance (IR) toward tetracycline. However, it was found to be susceptible to amoxiclav, chloramphenicol, erythromycin, azithromycin, and vancomycin. Bacitracin resistance of <italic>S. pyogenes</italic> in Europe was shown to be associated with the cMLSB phenotype-erm(B) genotype described (<xref rid="B59" ref-type="bibr">Silva-Costa et al., 2006</xref>). However, the isolates that were susceptible to tetracycline were also reported (<xref rid="B46" ref-type="bibr">Perez-Trallero et al., 2007</xref>). Furthermore, 66 Ciprofloxacin resistant isolates of <italic>S. pyogenes</italic> that were collected from infected children (<xref rid="B47" ref-type="bibr">Pires et al., 2010</xref>) and <italic>S. pyogenes</italic> isolates with reduced susceptibility to fluoroquinolones (<xref rid="B20" ref-type="bibr">Doloy et al., 2008</xref>), or with high-level resistance, have been observed and described earlier (<xref rid="B35" ref-type="bibr">Malhotra-Kumar et al., 2009</xref>). In addition, 45 bacitracin-resistant <italic>S. pyogenes</italic> isolates were reported among a batch of 1629 isolates (<xref rid="B49" ref-type="bibr">Pires et al., 2009</xref>). These reports have suggested that <italic>S. pyogenes</italic> are becoming resistant to the antibiotics available worldwide.</p><p>Based on the present antibiogram study, the NBMKU12 isolate was analyzed for the presence of 13 resistance genes encoding five antibiotics. The result showed the presence of only the Beta-lactem (<italic>TEM</italic>) gene. Although the novel isolate NBMKU12 is phenotypically resistant toward ampicillin and penicillin-G, it shows IR toward tetracycline. However, the mechanism of resistance rendered by these antibiotic resistance genes, is still elusive. Furthermore, the <italic>S. pyogenes</italic> efflux system encoding <italic>mef(A</italic>) gene was also not found. On the other hand, the <italic>bacA</italic> gene encoding bacitracin antibiotic resistance was found in <italic>S. pyogenes</italic> (<xref rid="B12" ref-type="bibr">Chalker et al., 2000</xref>). The presence of beta lactamase has been reported as a possible protective mechanism in group A beta hemolytic streptococci (GABHS) (<xref rid="B9" ref-type="bibr">Brook and Gilmore, 1993</xref>). Interestingly, we have also found the Beta-lactam resistance gene <italic>TEM</italic> in most of our isolates, including NBMKU12, which indicates its likely role in the resistance to beta-lactam antibiotics.</p><p>The streptococcal genes encode exotoxins, superantigens, and streptodornases, which are responsible for GAS virulence and pathogenesis (<xref rid="B29" ref-type="bibr">Igwe et al., 2003</xref>; <xref rid="B49" ref-type="bibr">Pires et al., 2009</xref>). Most of the diseases caused by GAS are probably due to the diversity of the virulent gene&#8217;s products mainly encoded by mobile genetic elements, i.e., prophages (<xref rid="B65" ref-type="bibr">Walker et al., 2014</xref>; <xref rid="B32" ref-type="bibr">Kuleshevich et al., 2017</xref>). Furthermore, streptococcal pyrogenic exotoxins (s<italic>peA</italic> or <italic>speC</italic>) and streptococcal superantigen (<italic>ssa</italic>) are bacteriophage encoded virulence factors that are associated with invasive diseases (<xref rid="B36" ref-type="bibr">McCormick et al., 2001</xref>). Moreover, streptococcal invasion caused by <italic>PrtF1</italic> mediates adherence and internalization by host epithelial cells (<xref rid="B50" ref-type="bibr">Pires et al., 2012</xref>). This study analyzed 13 virulent genes of different sizes, and among them streptococcal pyrogenic exotoxins <italic>speJ</italic> and <italic>speB</italic> genes were detected. The <italic>speB</italic> gene encoding for cysteine proteases, which are involved in the host tissue destruction during pathogenesis, was documented (<xref rid="B19" ref-type="bibr">Do et al., 2017</xref>).</p><p>During infection, GAS secreted cell associated proteins, such as toxins, superantigens, and proteases (<xref rid="B50" ref-type="bibr">Pires et al., 2012</xref>; <xref rid="B62" ref-type="bibr">Sumitomo et al., 2013</xref>). Despite these virulence factors, the GAS extracellular proteins are important for pathogenesis, especially in epithelial barrier dysfunction (<xref rid="B62" ref-type="bibr">Sumitomo et al., 2013</xref>). We have shown the evidence for <italic>speB</italic>, a broad spectrum secreted cysteine protease, which effectively digests cysteine substrates such as casein, papaya, and pineapple (bromelain). The culture supernatant from <italic>S. pyogenes</italic> strains SSI-9 and NZ131 is capable of cleaving the E-cadherin fragment (<xref rid="B62" ref-type="bibr">Sumitomo et al., 2013</xref>) whereas, <italic>speB</italic> coding cysteine protease cleaves intercellular junctions, and its proteolytic activity contributes to GAS translocation across the epithelial barrier (<xref rid="B62" ref-type="bibr">Sumitomo et al., 2013</xref>). In addition, <italic>speB</italic> extracellular protein of <italic>S. pyogenes</italic> culture supernatant degrades the host extracellular matrix, immunoglobulins, complementary components, and also streptococcal surface proteins (<xref rid="B40" ref-type="bibr">Nelson et al., 2011</xref>; <xref rid="B28" ref-type="bibr">Honda-Ogawa et al., 2013</xref>). We also noted that the NBMKU12 culture supernatants at different growth periods showed a varied efficiency of digestion of casein, papaya, and pineapple (bromelain) substrates. The cysteine protease secretion into the medium containing the three natural substrates, and their digestion, confirms the presence of predicted signal peptides. On the other hand, aspartic protease sc-asp113 have confirmed the presence of predicted signal peptides in putative protein (<xref rid="B4" ref-type="bibr">Balasubramanian et al., 2012b</xref>).</p><p>To understand the <italic>speB</italic> encoding cysteine protease interaction in NBMKU12 isolate, the 1.2 kb <italic>speB</italic> gene was amplified, cloned, and the gene sequenced. <italic>S. pyogenes</italic> NBMKU12 was found to be resistant to certain antibiotics. Therefore, to understand the <italic>speB</italic> cysteine protease interaction with commercial antibiotics, inhibitors, and substrates, a docking analysis was performed. The predicted secondary structure of cysteine protease was computed by SOPMA and the results revealed similarity to the model, except the coil region (<xref rid="B18" ref-type="bibr">Dhanavade et al., 2013</xref>), and very close to the model of <xref rid="B51" ref-type="bibr">Rana et al. (2017)</xref>. The major part of the cysteine protein was composed of random coil structure, followed by alpha helix, extended strand, and beta turns structures, and thus the results confirmed the stability of the protein. This computed value is very close to the model of cysteine protease YopT of <italic>Yersinia pestis</italic>, particularly the coil region (<xref rid="B2" ref-type="bibr">Anayet Hasan et al., 2014</xref>). The results of PROCHECK, PROSA and VERIFY-3D programs showed the model score to be 0.79, which is close to the template score (0.69). This score is also very close to the cysteine protease YopT of <italic>Yersinia pestis</italic> (<xref rid="B2" ref-type="bibr">Anayet Hasan et al., 2014</xref>).</p><p>The analysis of the energy profiles of docking conformations of cysteine protease with chloramphenicol, penicillin-G, erythromycin, and azithromycin have showed that erythromycin and azithromycin have lower docking energies. This is because of the existence of an increased number of interactions (<xref rid="B39" ref-type="bibr">Musyoka et al., 2016</xref>). Therefore, it can be inferred that erythromycin tightly interacts with cysteine protease resulting in increased stability and reduced flexibility (<xref rid="B58" ref-type="bibr">Siklos et al., 2015</xref>). Hence, this drug has higher significance, and azithromycin is placed in the next level of significance. Our wet lab results also infer the same confirmation, where the docking with the inhibitors Cystatin A, Cystatin B, and Cystatin S produce the score 15194, 18223, and 12115, respectively. The GLY 157 of Cystatin A plays a crucial role in the interaction of the inhibitor with cysteine protease, because this residue lies close to the receptor with 2.9 &#197; bond length and lower binding energy in comparison to other residual interactions. When compared with interaction profiles of azithromycin, this is a higher value, but is closer to the value of papain. The residues TRY67, ASP213, GLY66, and THR215 of cysteine protease interact with ALA2 and ALA3 of the substrate papain residues. Among these residual interactions, THR215 is found to have a short bond length of 2.59 &#197;. Our laboratory experiments and <italic>in silico</italic> analyses have confirmed the same findings for the isolate NBMKU12. The experimental results confirmed that the isolate NBMKU12 is resistant to penicillin-G and susceptible to erythromycin and azithromycin, followed by chloramphenicol.</p></sec><sec><title>Conclusion</title><p>The present study revealed the antibiotic resistant phenotype, genotype, and cloning of <italic>speB</italic> gene encoding cysteine protease and its putative protein interaction with commercially available antibiotics, which are currently being used in the treatment of <italic>streptococcus</italic> infections. Based on the cysteine protease and antibiotic interaction, we confirmed the antibiotic resistance and susceptibility of the isolate NBMKU12. Further investigations must focus on the production and purification of cysteine protease to evaluate the role of <italic>speB</italic> encoding cysteine protease in the pathogenesis of <italic>S. pyogenes</italic> NBMKU12 isolate.</p></sec><sec><title>Author Contributions</title><p>NB conducted the experiments, planned and wrote the manuscript. GV conducted the <italic>in silico</italic> analysis. VS helped to perform the experiments and write the manuscript. KB collaborated with the other authors to correct the manuscript. MT provided the sample and collaborated with the other authors to correct the manuscript.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>The author NB is thankful to DST-SERB, Government of India, New Delhi for financial support through Ramanujan Fellowship (No. SB/S2/RJN-201/2014). NB also greatly acknowledges the role of Apollo Hospital, Chennai, India in providing bacterial samples. All authors acknowledge the Chairperson, School of Biological Sciences and the Head, Department of Immunology, Madurai Kamaraj University, Madurai for providing laboratory facilities.</p></ack><fn-group><fn id="fn01"><label>1</label><p><ext-link ext-link-type="uri" xlink:href="http://smart.embl-heidelberg.de/">http://smart.embl-heidelberg.de/</ext-link></p></fn><fn id="fn02"><label>2</label><p><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi">http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi</ext-link></p></fn><fn id="fn03"><label>3</label><p><ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/SignalP/">http://www.cbs.dtu.dk/services/SignalP/</ext-link></p></fn><fn id="fn04"><label>4</label><p><ext-link ext-link-type="uri" xlink:href="http://www.cbs.dtu.dk/services/SecretomeP/">http://www.cbs.dtu.dk/services/SecretomeP/</ext-link></p></fn><fn id="fn05"><label>5</label><p><ext-link ext-link-type="uri" xlink:href="http://expasy.org/tools/protparam.html">http://expasy.org/tools/protparam.html</ext-link></p></fn><fn id="fn06"><label>6</label><p><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/BLAST/">http://www.ncbi.nlm.nih.gov/BLAST/</ext-link></p></fn><fn id="fn07"><label>7</label><p><ext-link ext-link-type="uri" xlink:href="http://PyMOL.sourceforge.net/">http://PyMOL.sourceforge.net/</ext-link></p></fn></fn-group><sec sec-type="supplementary material"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2018.01658/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2018.01658/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Table_1.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aminov</surname><given-names>R. I.</given-names></name><name><surname>Garrigues-Jeanjean</surname><given-names>N.</given-names></name><name><surname>Mackie</surname><given-names>R. I.</given-names></name></person-group> (<year>2001</year>). <article-title>Molecular ecology of tetracycline resistance: development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins.</article-title>
<source><italic>Appl. Environ. Microbiol.</italic></source>
<volume>67</volume>
<fpage>22</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.67.1.22-32.2001</pub-id>
<?supplied-pmid 11133424?><pub-id pub-id-type="pmid">11133424</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anayet Hasan</surname><given-names>M.</given-names></name><name><surname>Alauddin</surname><given-names>S. M.</given-names></name><name><surname>Ai Amin</surname><given-names>M.</given-names></name><name><surname>Mohammad Nur</surname><given-names>S.</given-names></name><name><surname>Mannan</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title><italic>Insilico</italic> molecular characterization of cystein protease YopT from <italic>Yersinia pestis</italic> by homology modeling and binding site identification.</article-title>
<source><italic>Drug Target Insights</italic></source>
<volume>8</volume>
<fpage>1</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4137/DTI.S13529</pub-id>
<?supplied-pmid 24526834?><pub-id pub-id-type="pmid">24526834</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>N.</given-names></name><name><surname>Toubarro</surname><given-names>D.</given-names></name><name><surname>Teixeira</surname><given-names>M.</given-names></name><name><surname>Sim&#245;s</surname><given-names>N.</given-names></name></person-group> (<year>2012a</year>). <article-title>Purification and biochemical characterization of a novel thermo-stable carboxymethyl cellulase from azorean isolate <italic>Bacillus mycoides</italic> S122C.</article-title>
<source><italic>Appl. Biochem. Biotechnol</italic></source>
<volume>168</volume>
<fpage>2191</fpage>&#8211;<lpage>2204</lpage>. <pub-id pub-id-type="doi">10.1007/s12010-012-9929-8</pub-id>
<?supplied-pmid 23070713?><pub-id pub-id-type="pmid">23070713</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>N.</given-names></name><name><surname>Toubarro</surname><given-names>D.</given-names></name><name><surname>Nascimento</surname><given-names>G.</given-names></name><name><surname>Ferreira</surname><given-names>R.</given-names></name><name><surname>Sim&#245;es</surname><given-names>N.</given-names></name></person-group> (<year>2012b</year>). <article-title>Purification, molecular characterization and gene expression analysis of an aspartic protease (Sc-ASP113) from the nematode <italic>Steinernema carpocapsae</italic> during the parasitic stage.</article-title>
<source><italic>Mol. Biochem. Parasitol.</italic></source>
<volume>182</volume>
<fpage>37</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbiopara.2011.12.001</pub-id>
<?supplied-pmid 22178695?><pub-id pub-id-type="pmid">22178695</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassetti</surname><given-names>M.</given-names></name><name><surname>Manno</surname><given-names>G.</given-names></name><name><surname>Collid&#224;</surname><given-names>A.</given-names></name><name><surname>Ferrando</surname><given-names>A.</given-names></name><name><surname>Gatti</surname><given-names>G.</given-names></name><name><surname>Ugolotti</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Erythromycin resistance in <italic>Streptococcus pyogenes</italic> in italy.</article-title>
<source><italic>Emerg. Infect. Dis.</italic></source>
<volume>6</volume>
<fpage>180</fpage>&#8211;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.3201/eid0602.000212</pub-id>
<?supplied-pmid 10756153?><pub-id pub-id-type="pmid">10756153</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binghuai</surname><given-names>L.</given-names></name><name><surname>Yanli</surname><given-names>S.</given-names></name><name><surname>Shuchen</surname><given-names>Z.</given-names></name><name><surname>Fengxia</surname><given-names>Z.</given-names></name><name><surname>Dong</surname><given-names>L.</given-names></name><name><surname>Yanchao</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Use of MALDI-TOF mass spectrometry for rapid identification of group B Streptococcus on chromID Strepto B agar.</article-title>
<source><italic>Int. J. Infect. Dis.</italic></source>
<volume>27</volume>
<fpage>44</fpage>&#8211;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2014.06.023</pub-id>
<?supplied-pmid 25220051?><pub-id pub-id-type="pmid">25220051</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname><given-names>A. C.</given-names></name><name><surname>Lilliebridge</surname><given-names>R. A.</given-names></name><name><surname>Tong</surname><given-names>S. Y.</given-names></name><name><surname>Baird</surname><given-names>R. W.</given-names></name><name><surname>Ward</surname><given-names>P.</given-names></name><name><surname>McDonald</surname><given-names>M. I.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Is <italic>Streptococcus pyogenes</italic> resistant or susceptible to trimethoprim-sulfamethoxazole?</article-title>
<source><italic>J. Clin. Microbiol.</italic></source>
<volume>50</volume>
<fpage>4067</fpage>&#8211;<lpage>4072</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.02195-12</pub-id>
<?supplied-pmid 23052313?><pub-id pub-id-type="pmid">23052313</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I.</given-names></name><name><surname>Dohar</surname><given-names>J. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Management of group A beta-hemolytic streptococcal pharyngotonsillitis in children.</article-title>
<source><italic>J. Fam. Pract.</italic></source>
<volume>55</volume>
<fpage>S1</fpage>&#8211;<lpage>S11</lpage>. <?supplied-pmid 17137534?><pub-id pub-id-type="pmid">17137534</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brook</surname><given-names>I.</given-names></name><name><surname>Gilmore</surname><given-names>J. D.</given-names></name></person-group> (<year>1993</year>). <article-title>Evaluation of bacterial interference and &#946;-lactamase production in management of experimental infection with group beta-hemolytic streptococci.</article-title>
<source><italic>Antimicrob. Agents Chemo.</italic></source>
<volume>37</volume>
<fpage>1452</fpage>&#8211;<lpage>1455</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.37.7.1452</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camara</surname><given-names>M.</given-names></name><name><surname>Dieng</surname><given-names>A.</given-names></name><name><surname>Bouh Boye</surname><given-names>C. S.</given-names></name></person-group> (<year>2013</year>). <article-title>Antibiotic susceptibility of <italic>Streptococcus pyogenes</italic> isolated from respiratory tract infections in dakar. Senegal.</article-title>
<source><italic>Microbiol. Insights</italic></source>
<volume>6</volume>
<fpage>71</fpage>&#8211;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.4137/MBI.S12996</pub-id>
<?supplied-pmid 24826076?><pub-id pub-id-type="pmid">24826076</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carbonnelle</surname><given-names>E.</given-names></name><name><surname>Mesquita</surname><given-names>C.</given-names></name><name><surname>Bille</surname><given-names>E.</given-names></name><name><surname>Day</surname><given-names>N.</given-names></name><name><surname>Dauphin</surname><given-names>B.</given-names></name><name><surname>Beretti</surname><given-names>L. L.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory.</article-title>
<source><italic>Clin. Biochem.</italic></source>
<volume>44</volume>
<fpage>104</fpage>&#8211;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.clinbiochem.2010.06.017</pub-id>
<?supplied-pmid 20620134?><pub-id pub-id-type="pmid">20620134</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chalker</surname><given-names>A. F.</given-names></name><name><surname>Ingraham</surname><given-names>K. A.</given-names></name><name><surname>Lunsford</surname><given-names>R. D.</given-names></name><name><surname>Bryant</surname><given-names>A. P.</given-names></name><name><surname>Bryant</surname><given-names>J.</given-names></name><name><surname>Wallis</surname><given-names>N. G.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>The <italic>bacA</italic> gene, which determines bacitracin susceptibility in <italic>Streptococcus pneumoniae</italic> and <italic>Staphylococcus aureus</italic>, is also required for virulence.</article-title>
<source><italic>Microbiology</italic></source>
<volume>146</volume>
<fpage>1547</fpage>&#8211;<lpage>1553</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-146-7-1547</pub-id>
<?supplied-pmid 10878119?><pub-id pub-id-type="pmid">10878119</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><name><surname>Fu</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Antibiotic resistance and molecular analysis of <italic>Streptococcus pyogenes</italic> isolated from healthy school children in China.</article-title>
<source><italic>Scand. J. Infect. Dis.</italic></source>
<volume>42</volume>
<fpage>84</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.3109/00365540903321598</pub-id>
<?supplied-pmid 19883153?><pub-id pub-id-type="pmid">19883153</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="book"><collab>CLSI</collab> (<year>2006</year>). <source><italic>Performance Standards for Antimicrobial Disk Susceptibility Tests</italic></source>, <edition>9th Edn</edition>
<publisher-loc>Wayne, PA</publisher-loc>: <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>.</mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coffey</surname><given-names>T. J.</given-names></name><name><surname>Dowson</surname><given-names>C. G.</given-names></name><name><surname>Daniels</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Martin</surname><given-names>C.</given-names></name><name><surname>Spratt</surname><given-names>B. G.</given-names></name><etal/></person-group> (<year>1991</year>). <article-title>Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of <italic>Streptococcus pneumoniae</italic>.</article-title>
<source><italic>Mol. Microbio.</italic></source>
<volume>5</volume>
<fpage>2255</fpage>&#8211;<lpage>2260</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.1991.tb02155.x</pub-id>
<?supplied-pmid 1766389?><pub-id pub-id-type="pmid">1766389</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cstorer</surname><given-names>A.</given-names></name><name><surname>Menard</surname><given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>Catalytic mechanism in papain family of cysteine peptidases.</article-title>
<source><italic>Meth. Enzymol.</italic></source>
<volume>244</volume>
<fpage>486</fpage>&#8211;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1016/0076-6879(94)44035-2</pub-id><pub-id pub-id-type="pmid">7845227</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>M. W.</given-names></name></person-group> (<year>2000</year>). <article-title>Pathogenesis of Group A Streptococcal infections.</article-title>
<source><italic>Clin. Microbiol. Rev.</italic></source>
<volume>13</volume>
<fpage>470</fpage>&#8211;<lpage>511</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.13.3.470-511.2000</pub-id><pub-id pub-id-type="pmid">10885988</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhanavade</surname><given-names>M. J.</given-names></name><name><surname>Chidambar</surname><given-names>B. J.</given-names></name><name><surname>Barage</surname><given-names>S. H.</given-names></name><name><surname>Sonawane</surname><given-names>K. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Homology modeling, molecular docking and MD simulation studies to investigate role of cysteine protease from <italic>Xanthomonas campestris</italic> in degradation of A&#946; peptide.</article-title>
<source><italic>Comput. Biol. Med.</italic></source>
<volume>43</volume>
<fpage>2063</fpage>&#8211;<lpage>2070</lpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2013.09.021</pub-id>
<?supplied-pmid 24290922?><pub-id pub-id-type="pmid">24290922</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname><given-names>H.</given-names></name><name><surname>Makthal</surname><given-names>N.</given-names></name><name><surname>VanderWal</surname><given-names>A. R.</given-names></name><name><surname>Rettel</surname><given-names>M.</given-names></name><name><surname>Savitski</surname><given-names>M. M.</given-names></name><name><surname>Peschek</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Leaderless secreted peptide signaling molecule alters global gene expression and increases virulence of a human bacterial pathogen.</article-title>
<source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source>
<volume>114</volume>
<fpage>E8498</fpage>&#8211;<lpage>E8507</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1705972114</pub-id>
<?supplied-pmid 28923955?><pub-id pub-id-type="pmid">28923955</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doloy</surname><given-names>A. C.</given-names></name><name><surname>Godin</surname><given-names>J. W.</given-names></name><name><surname>Decousser</surname><given-names>P.</given-names></name><name><surname>Panel</surname><given-names>A.</given-names></name><name><surname>Greder-Belan</surname><given-names>A.</given-names></name><name><surname>Doucet-Populaire</surname><given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Primary peritonitis due to <italic>Streptococcus pyogenes</italic> with reduced susceptibility to fluoroquinolones.</article-title>
<source><italic>Diagn. Microbiol. Infect. Dis.</italic></source>
<volume>62</volume>
<fpage>447</fpage>&#8211;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2008.08.001</pub-id>
<?supplied-pmid 18842379?><pub-id pub-id-type="pmid">18842379</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenberg</surname><given-names>D.</given-names></name><name><surname>Luthy</surname><given-names>R.</given-names></name><name><surname>Bowie</surname><given-names>J. U.</given-names></name></person-group> (<year>1997</year>). <article-title>VERIFY 3D: assessment of protein models with three-dimensional profiles.</article-title>
<source><italic>Methods Enzymol.</italic></source>
<volume>277</volume>
<fpage>396</fpage>&#8211;<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1016/S0076-6879(97)77022-8</pub-id>
<?supplied-pmid 1538787?><pub-id pub-id-type="pmid">9379925</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>A.</given-names></name><name><surname>Norgren</surname><given-names>M.</given-names></name></person-group> (<year>2003</year>). <article-title>Cleavage of antigen-bound immunoglobulinG by SpeB contributes to streptococcal persistence in opsonizing blood.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>71</volume>
<fpage>211</fpage>&#8211;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.71.1.211-217.2003</pub-id>
<?supplied-pmid 12496168?><pub-id pub-id-type="pmid">12496168</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Facklam</surname><given-names>R.</given-names></name></person-group> (<year>2002</year>). <article-title>What happened to the streptococci: overview of taxonomic and nomenclature changes.</article-title>
<source><italic>Clin. Microbiol. Rev.</italic></source>
<volume>15</volume>
<fpage>613</fpage>&#8211;<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.15.4.613-630.2002</pub-id>
<?supplied-pmid 12364372?><pub-id pub-id-type="pmid">12364372</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felmingham</surname><given-names>D.</given-names></name><name><surname>Farrell</surname><given-names>D. J.</given-names></name><name><surname>Reinert</surname><given-names>R. R.</given-names></name><name><surname>Morrissey</surname><given-names>I.</given-names></name></person-group> (<year>2004</year>). <article-title>Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999&#8211;2000).</article-title>
<source><italic>J. Infect.</italic></source>
<volume>48</volume>
<fpage>39</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/S0163-4453(03)00140-3</pub-id><pub-id pub-id-type="pmid">14667791</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gasteiger</surname><given-names>E.</given-names></name><name><surname>Hoogland</surname><given-names>C.</given-names></name><name><surname>Gattiker</surname><given-names>A.</given-names></name><name><surname>Duvaud</surname><given-names>S.</given-names></name><name><surname>Wilkins</surname><given-names>M. R.</given-names></name><name><surname>Appel</surname><given-names>R. D.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>&#8220;Protein identification and analysis tools on the EXPASY server,&#8221; in</article-title>
<source><italic>The Proteomics Protocols Handbook</italic></source>, <role>ed.</role>
<person-group person-group-type="editor"><name><surname>Walker</surname><given-names>J. M.</given-names></name></person-group> (<publisher-loc>New York NY</publisher-loc>: <publisher-name>Humana Press</publisher-name>), <fpage>571</fpage>&#8211;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1385/1-59259-890-0:571</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geourjon</surname><given-names>C.</given-names></name><name><surname>Del&#233;age</surname><given-names>G.</given-names></name></person-group> (<year>1995</year>). <article-title>SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments.</article-title>
<source><italic>Comput. Appl. Biosci.</italic></source>
<volume>11</volume>
<fpage>681</fpage>&#8211;<lpage>684</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/11.6.681</pub-id>
<?supplied-pmid 8808585?><pub-id pub-id-type="pmid">8808585</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grzonka</surname><given-names>Z.</given-names></name><name><surname>Jankowska</surname><given-names>E.</given-names></name><name><surname>Kasprzykowski</surname><given-names>F.</given-names></name><name><surname>Kasprzykowska</surname><given-names>R.</given-names></name><name><surname>Lankiewicz</surname><given-names>L.</given-names></name><name><surname>Wiczk</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Structural studies of cysteine proteases and their inhibitors.</article-title>
<source><italic>Acta. Biochim. Pol.</italic></source>
<volume>48</volume>
<fpage>1</fpage>&#8211;<lpage>20</lpage>.<pub-id pub-id-type="pmid">11440158</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda-Ogawa</surname><given-names>M.</given-names></name><name><surname>Ogawa</surname><given-names>T.</given-names></name><name><surname>Terao</surname><given-names>Y.</given-names></name><name><surname>Sumitomo</surname><given-names>T.</given-names></name><name><surname>Nakata</surname><given-names>M. K.</given-names></name><name><surname>Ikebe</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Cysteine proteinase from <italic>Streptococcus pyogenes</italic> enables evasion of innate immunity via degradation of complement factors.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>288</volume>
<fpage>15854</fpage>&#8211;<lpage>15864</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.469106</pub-id>
<?supplied-pmid 23589297?><pub-id pub-id-type="pmid">23589297</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igwe</surname><given-names>E. I.</given-names></name><name><surname>Shewmaker</surname><given-names>P. L.</given-names></name><name><surname>Facklam</surname><given-names>R. R.</given-names></name><name><surname>Farley</surname><given-names>M. M.</given-names></name><name><surname>van Beneden</surname><given-names>C.</given-names></name><name><surname>Beall</surname><given-names>B.</given-names></name></person-group> (<year>2003</year>). <article-title>Identification of superantigen genes spam, <italic>SSA</italic>, and <italic>SMEZ</italic> in invasive strains of beta-hemolytic group C and G streptococci recovered from humans.</article-title>
<source><italic>FEMS Microbiol. Lett.</italic></source>
<volume>229</volume>
<fpage>259</fpage>&#8211;<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1016/S0378-1097(03)00842-5</pub-id><pub-id pub-id-type="pmid">14680708</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname><given-names>H. B.</given-names></name><name><surname>Ning</surname><given-names>B. A.</given-names></name><name><surname>Hao</surname><given-names>H. J.</given-names></name><name><surname>Zheng</surname><given-names>Y. L.</given-names></name><name><surname>Chang</surname><given-names>D.</given-names></name><name><surname>Jiang</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Epidemiological analysis of group A streptococci recovered from patients in China.</article-title>
<source><italic>J. Med. Microbiol.</italic></source>
<volume>55</volume>
<fpage>1101</fpage>&#8211;<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1099/jmm.0.46243-0</pub-id>
<?supplied-pmid 16849731?><pub-id pub-id-type="pmid">16849731</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapur</surname><given-names>V.</given-names></name><name><surname>Topouzis</surname><given-names>S.</given-names></name><name><surname>Majesky</surname><given-names>M. W.</given-names></name><name><surname>Li</surname><given-names>L. L.</given-names></name><name><surname>Hamrick</surname><given-names>M. R.</given-names></name><name><surname>Hamill</surname><given-names>R. J.</given-names></name><etal/></person-group> (<year>1993</year>). <article-title>A conserved <italic>Streptococcus pyogenes</italic> extracellular cysteine protease cleaves human fibronectin and degrades vitronectin.</article-title>
<source><italic>Microb. Pathog.</italic></source>
<volume>15</volume>
<fpage>327</fpage>&#8211;<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1006/mpat.1993.1083</pub-id>
<?supplied-pmid 7516997?><pub-id pub-id-type="pmid">7516997</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuleshevich</surname><given-names>E.</given-names></name><name><surname>Ferretti</surname><given-names>J.</given-names></name><name><surname>Santos Sanches</surname><given-names>I.</given-names></name><name><surname>Balasubramanian</surname><given-names>N.</given-names></name><name><surname>Spellerberg</surname><given-names>B.</given-names></name><name><surname>Efstratiou</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Clinical strains of <italic>Streptococcus agalactiae</italic> carry two different variants of pathogenicity island XII.</article-title>
<source><italic>Folia Microbiol.</italic></source>
<volume>62</volume>:<issue>393</issue>. <pub-id pub-id-type="doi">10.1007/s12223-017-0509-8</pub-id>
<?supplied-pmid 28315021?><pub-id pub-id-type="pmid">28315021</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lartigue</surname><given-names>M. F.</given-names></name><name><surname>H&#233;ry-Arnaud</surname><given-names>G.</given-names></name><name><surname>Haguenoer</surname><given-names>E.</given-names></name><name><surname>Domelier</surname><given-names>A. S.</given-names></name><name><surname>Schmit</surname><given-names>P. O.</given-names></name><name><surname>van der Mee-Marquet</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Identification of <italic>Streptococcus agalactiae</italic> isolates from various phylogenetic lineages by matrix-assisted laser desorption ionization-time of flight mass spectrometry.</article-title>
<source><italic>J. Clin. Microbiol.</italic></source>
<volume>47</volume>
<fpage>2284</fpage>&#8211;<lpage>2287</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00175-09</pub-id>
<?supplied-pmid 19403759?><pub-id pub-id-type="pmid">19403759</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laskowaski</surname><given-names>R. A.</given-names></name><name><surname>McArther</surname><given-names>M. M.</given-names></name><name><surname>Moss</surname><given-names>D. S.</given-names></name><name><surname>Thornton</surname><given-names>J. M.</given-names></name></person-group> (<year>1993</year>). <article-title>PROCHECK a program to check sterio-chemical quality of a protein structures.</article-title>
<source><italic>J. Appl. Crystallogr.</italic></source>
<volume>26</volume>
<fpage>283</fpage>&#8211;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1107/S0021889892009944</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra-Kumar</surname><given-names>S.</given-names></name><name><surname>Van Heirstraeten</surname><given-names>L.</given-names></name><name><surname>Lammens</surname><given-names>C.</given-names></name><name><surname>Chapelle</surname><given-names>S.</given-names></name><name><surname>Goossens</surname><given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Emergence of high-level fluoroquinolone resistance in emm6 <italic>Streptococcus pyogenes</italic> and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.</article-title>
<source><italic>J. Antimicrob. Chemother.</italic></source>
<volume>63</volume>
<fpage>886</fpage>&#8211;<lpage>894</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkp057</pub-id>
<?supplied-pmid 19279051?><pub-id pub-id-type="pmid">19279051</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>J. K.</given-names></name><name><surname>Yarwood</surname><given-names>J. M.</given-names></name><name><surname>Schlievert</surname><given-names>P. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Toxic shock syndrome and bacterial superantigens: an update.</article-title>
<source><italic>Annu. Rev. Microbiol.</italic></source>
<volume>55</volume>
<fpage>77</fpage>&#8211;<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.micro.55.1.77</pub-id><pub-id pub-id-type="pmid">11544350</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>G. M.</given-names></name><name><surname>Huey</surname><given-names>R.</given-names></name><name><surname>Lindstrom</surname><given-names>W.</given-names></name><name><surname>Sanner</surname><given-names>M. F.</given-names></name><name><surname>Belew</surname><given-names>R. K.</given-names></name><name><surname>Goodsell</surname><given-names>D. S.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility.</article-title>
<source><italic>J. Comput. Chem.</italic></source>
<volume>30</volume>
<fpage>2785</fpage>&#8211;<lpage>2791</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.21256</pub-id>
<?supplied-pmid 19399780?><pub-id pub-id-type="pmid">19399780</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#241;oz</surname><given-names>R.</given-names></name><name><surname>Coffey</surname><given-names>T. J.</given-names></name><name><surname>Daniels</surname><given-names>M.</given-names></name><name><surname>Dowson</surname><given-names>C. G.</given-names></name><name><surname>Laible</surname><given-names>G.</given-names></name><name><surname>Casal</surname><given-names>J.</given-names></name><etal/></person-group> (<year>1991</year>). <article-title>Intercontinental spread of a multiresistant clone of serotype 23F <italic>Streptococcus pneumoniae</italic>.</article-title>
<source><italic>J. Infect. Dis.</italic></source>
<volume>164</volume>
<fpage>302</fpage>&#8211;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/164.2.302</pub-id>
<?supplied-pmid 1856478?><pub-id pub-id-type="pmid">1856478</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musyoka</surname><given-names>T. M.</given-names></name><name><surname>Kanzi</surname><given-names>A. M.</given-names></name><name><surname>Lobb</surname><given-names>K. A.</given-names></name><name><surname>Bishop</surname><given-names>O. T.</given-names></name></person-group> (<year>2016</year>). <article-title>Structure based docking and molecular dynamic studies of plasmodial cysteine proteases against a south african natural compound and its analogs.</article-title>
<source><italic>Sci. Rep.</italic></source>
<volume>6</volume>:<issue>23690</issue>. <pub-id pub-id-type="doi">10.1038/srep23690</pub-id>
<?supplied-pmid 27030511?><pub-id pub-id-type="pmid">27030511</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>D. C.</given-names></name><name><surname>Garbe</surname><given-names>J.</given-names></name><name><surname>Collin</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Cysteine proteinase SpeB from <italic>Streptococcus pyogenes</italic>. A potent modifier of immunologically important host and bacterial proteins.</article-title>
<source><italic>Biol. Chem.</italic></source>
<volume>392</volume>
<fpage>1077</fpage>&#8211;<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.1515/BC.2011.208</pub-id>
<?supplied-pmid 22050223?><pub-id pub-id-type="pmid">22050223</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>L. K.</given-names></name><name><surname>Martin</surname><given-names>I.</given-names></name><name><surname>Alfa</surname><given-names>M.</given-names></name><name><surname>Mulvey</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Multiplex PCR for the detection of tetracycline resistant genes.</article-title>
<source><italic>Mol. Cell. Probes</italic></source>
<volume>15</volume>
<fpage>209</fpage>&#8211;<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1006/mcpr.2001.0363</pub-id>
<?supplied-pmid 11513555?><pub-id pub-id-type="pmid">11513555</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>S.</given-names></name><name><surname>S&#225;-Leao</surname><given-names>R.</given-names></name><name><surname>Carric</surname><given-names>J.</given-names></name><name><surname>Alves</surname><given-names>C. R.</given-names></name><name><surname>Mato</surname><given-names>R.</given-names></name><name><surname>Brito Avo</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Trends in drug resistance, serotypes, and molecular types of <italic>Streptococcus pneumoniae</italic> colonizing preschool-age children attending day care centers in lisbon, portugal: a summary of 4 years of annual surveillance.</article-title>
<source><italic>J. Clin. Microbiol.</italic></source>
<volume>43</volume>
<fpage>1285</fpage>&#8211;<lpage>1293</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.43.3.1285-1293.2005</pub-id>
<?supplied-pmid 15750097?><pub-id pub-id-type="pmid">15750097</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>J. G.</given-names></name><name><surname>Dagil</surname><given-names>R.</given-names></name><name><surname>Niclasen</surname><given-names>L. M.</given-names></name><name><surname>Soerensen</surname><given-names>O. E.</given-names></name><name><surname>Kragelund</surname><given-names>B. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Structure of the mature Streptococcal cysteine protease exotoxin mSpeB in its active dimeric form.</article-title>
<source><italic>J. Mol. Biol.</italic></source>
<volume>393</volume>
<fpage>693</fpage>&#8211;<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2009.08.046</pub-id>
<?supplied-pmid 19712682?><pub-id pub-id-type="pmid">19712682</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>R. J.</given-names></name><name><surname>Raghuram</surname><given-names>A.</given-names></name><name><surname>Cantu</surname><given-names>C.</given-names></name><name><surname>Hartman</surname><given-names>M. H.</given-names></name><name><surname>Jimenez</surname><given-names>F. E.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The majority of 9,729 Group A Streptococcus strains causing disease secrete SpeB cysteine protease: pathogenesis implications.</article-title>
<source><italic>Infect. Immun.</italic></source>
<volume>83</volume>
<fpage>4750</fpage>&#8211;<lpage>4758</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00989-15</pub-id>
<?supplied-pmid 26416912?><pub-id pub-id-type="pmid">26416912</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pe&#226;rez-Sancho</surname><given-names>M.</given-names></name><name><surname>Vela</surname><given-names>A. I.</given-names></name><name><surname>Garc&#245;&#226;a-Seco</surname><given-names>T.</given-names></name><name><surname>Gonza&#226;lez</surname><given-names>S.</given-names></name><name><surname>Dom&#245;&#226;nguez</surname><given-names>V.</given-names></name><name><surname>Ferna&#226;ndez-Garayza&#226;bal</surname><given-names>J. F.</given-names></name></person-group> (<year>2017</year>). <article-title>Usefulness of MALDI-TOF MS as a diagnostic tool for the identification of <italic>Streptococcus</italic> species recovered from clinical specimens of pigs.</article-title>
<source><italic>PLoS One</italic></source>
<volume>12</volume>:<issue>e0170784</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0170784</pub-id>
<?supplied-pmid 28125697?><pub-id pub-id-type="pmid">28125697</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Trallero</surname><given-names>E.</given-names></name><name><surname>Montes</surname><given-names>M.</given-names></name><name><surname>Orden</surname><given-names>B.</given-names></name><name><surname>Tamayo</surname><given-names>E.</given-names></name><name><surname>Garcia- Arenzana</surname><given-names>J. M.</given-names></name><name><surname>Marimon</surname><given-names>J. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Phenotypic and genotypic characterization of <italic>Streptococcus pyogenes</italic> isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>51</volume>
<fpage>1228</fpage>&#8211;<lpage>1233.</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.01054-06</pub-id>
<?supplied-pmid 17242142?><pub-id pub-id-type="pmid">17242142</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pires</surname><given-names>R.</given-names></name><name><surname>Ardanuy</surname><given-names>C.</given-names></name><name><surname>Rolo</surname><given-names>D.</given-names></name><name><surname>Morais</surname><given-names>A.</given-names></name><name><surname>Brito-Avo</surname><given-names>A.</given-names></name><name><surname>Goncalo-Marques</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Emergence of ciprofloxacin-nonsusceptible <italic>Streptococcus pyogenes</italic> isolates from healthy children and pediatric patients in portugal.</article-title>
<source><italic>Antimicrob. Agents Chemother.</italic></source>
<volume>54</volume>
<fpage>2677</fpage>&#8211;<lpage>2680</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01536-09</pub-id>
<?supplied-pmid 20350943?><pub-id pub-id-type="pmid">20350943</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pires</surname><given-names>R.</given-names></name><name><surname>Rolo</surname><given-names>D.</given-names></name><name><surname>Gama-Norton</surname><given-names>L.</given-names></name><name><surname>Morais</surname><given-names>A.</given-names></name><name><surname>Lito</surname><given-names>L.</given-names></name><name><surname>Salgado</surname><given-names>M. J.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Group A streptococci from carriage and disease in portugal: evolution of antimicrobial resistance and T antigenic types during 2000&#8211;2002.</article-title>
<source><italic>Microb. Drug Resist.</italic></source>
<volume>11</volume>
<fpage>360</fpage>&#8211;<lpage>370</lpage>. <pub-id pub-id-type="doi">10.1089/mdr.2005.11.360</pub-id>
<?supplied-pmid 16359196?><pub-id pub-id-type="pmid">16359196</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pires</surname><given-names>R.</given-names></name><name><surname>Rolo</surname><given-names>D.</given-names></name><name><surname>Mato</surname><given-names>R.</given-names></name><name><surname>de Almeida</surname><given-names>J. F.</given-names></name><name><surname>Johansson</surname><given-names>C.</given-names></name><name><surname>Henriques-Normark</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Resistance to bacitracin in <italic>Streptococcus pyogenes</italic> from oropharyngeal colonization and noninvasive infections in portugal was caused by two clones of distinct virulence genotypes.</article-title>
<source><italic>FEMS Microbiol. Lett.</italic></source>
<volume>296</volume>
<fpage>235</fpage>&#8211;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-6968.2009.01642.x</pub-id>
<?supplied-pmid 19486163?><pub-id pub-id-type="pmid">19486163</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pires</surname><given-names>R.</given-names></name><name><surname>Rolo</surname><given-names>D.</given-names></name><name><surname>Morais</surname><given-names>A.</given-names></name><name><surname>Brito-Av&#244;</surname><given-names>A.</given-names></name><name><surname>Johansson</surname><given-names>C.</given-names></name><name><surname>Henriques-Normark</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Description of macrolide-resistant and potential virulent clones of <italic>Streptococcus pyogenes</italic> causing asymptomatic colonization during 2000&#8211;2006 in the Lisbon area.</article-title>
<source><italic>Eur. J. Clin. Microbiol. Infect. Dis.</italic></source>
<volume>31</volume>
<fpage>849</fpage>&#8211;<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1007/s10096-011-1384-x</pub-id>
<?supplied-pmid 22012657?><pub-id pub-id-type="pmid">22012657</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rana</surname><given-names>S.</given-names></name><name><surname>Mahat</surname><given-names>J. P.</given-names></name><name><surname>Kumar</surname><given-names>M.</given-names></name><name><surname>Sarsaiya</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Modeling and docking of cysteine protease-A (CPA) of leishmania donovani.</article-title>
<source><italic>J. Appl. Pharm. Sci.</italic></source>
<volume>7</volume>
<fpage>179</fpage>&#8211;<lpage>184</lpage>.</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rato</surname><given-names>M. G.</given-names></name><name><surname>Bexiga</surname><given-names>R.</given-names></name><name><surname>Nunes</surname><given-names>S. F.</given-names></name><name><surname>Vilela</surname><given-names>C. L.</given-names></name><name><surname>Santos-Sanches</surname><given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>Human group a Streptococci virulence genes in bovine group c. Streptococci.</article-title>
<source><italic>Emerg. Infect. Dis.</italic></source>
<volume>16</volume>
<fpage>116</fpage>&#8211;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.3201/eid1601.090632</pub-id>
<?supplied-pmid 20031055?><pub-id pub-id-type="pmid">20031055</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rato</surname><given-names>M. G.</given-names></name><name><surname>Nerlich</surname><given-names>A.</given-names></name><name><surname>Bergmann</surname><given-names>R.</given-names></name><name><surname>Bexiga</surname><given-names>R.</given-names></name><name><surname>Nunes</surname><given-names>S. F.</given-names></name><name><surname>Vilela</surname><given-names>C. L.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Virulence gene pool detected in bovine Group C <italic>Streptococcus dysgalactiae</italic> subsp. <italic>dysgalactiae</italic> isolates by use of a Group A <italic>S. pyogenes</italic> virulence microarray.</article-title>
<source><italic>J. Clin. Microbiol.</italic></source>
<volume>49</volume>
<fpage>2470</fpage>&#8211;<lpage>2479</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.00008-11</pub-id>
<?supplied-pmid 21525223?><pub-id pub-id-type="pmid">21525223</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawlings</surname><given-names>N. D.</given-names></name><name><surname>Barrett</surname><given-names>A. J.</given-names></name><name><surname>Bateman</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>MEROPS: the database of proteolytic enzymes, their substrates and inhibitors.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>40</volume>
<fpage>343</fpage>&#8211;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkr987</pub-id>
<?supplied-pmid 22086950?><pub-id pub-id-type="pmid">22086950</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richter</surname><given-names>F.</given-names></name><name><surname>Blomberg</surname><given-names>R.</given-names></name><name><surname>Khare</surname><given-names>S. D.</given-names></name><name><surname>Kiss</surname><given-names>G.</given-names></name><name><surname>Kuzin</surname><given-names>A. P.</given-names></name><name><surname>Smith</surname><given-names>A. J. T.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Computational design of catalytic dyads and oxyanion holes for ester hydrolysis.</article-title>
<source><italic>J. Am. Chem. Soc.</italic></source>
<volume>134</volume>
<fpage>16197</fpage>&#8211;<lpage>16206</lpage>. <pub-id pub-id-type="doi">10.1021/ja3037367</pub-id>
<?supplied-pmid 22871159?><pub-id pub-id-type="pmid">22871159</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sali</surname><given-names>A.</given-names></name><name><surname>Blundell</surname><given-names>T. L.</given-names></name></person-group> (<year>1993</year>). <article-title>Comparative protein modeling by satisfaction of spatial restraints.</article-title>
<source><italic>J. Mol. Biol.</italic></source>
<volume>234</volume>
<fpage>779</fpage>&#8211;<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.1993.1626</pub-id>
<?supplied-pmid 8254673?><pub-id pub-id-type="pmid">8254673</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneidman-Duhovny</surname><given-names>D.</given-names></name><name><surname>Inbar</surname><given-names>Y.</given-names></name><name><surname>Nussinov</surname><given-names>R.</given-names></name><name><surname>Wolfson</surname><given-names>H. J.</given-names></name></person-group> (<year>2005</year>). <article-title>PatchDock and SymmDock: servers for rigid and symmetric docking.</article-title>
<source><italic>Nucleic Acids. Res.</italic></source>
<volume>33</volume>
<fpage>363</fpage>&#8211;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki48</pub-id>
<?supplied-pmid 15980490?><pub-id pub-id-type="pmid">15980490</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siklos</surname><given-names>M.</given-names></name><name><surname>BenAissa</surname><given-names>M.</given-names></name><name><surname>Gregory</surname><given-names>R.</given-names></name><name><surname>Thatcher</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.</article-title>
<source><italic>Acta Pharm. Sin. B</italic></source>
<volume>5</volume>
<fpage>506</fpage>&#8211;<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2015.08.001</pub-id>
<?supplied-pmid 26713267?><pub-id pub-id-type="pmid">26713267</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva-Costa</surname><given-names>C.</given-names></name><name><surname>Ramirez</surname><given-names>M.</given-names></name><name><surname>Melo-Cristino</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Identification of macrolide-resistant clones of <italic>Streptococcus pyogenes</italic> in Portugal.</article-title>
<source><italic>Clin. Microbiol. Infect.</italic></source>
<volume>12</volume>
<fpage>513</fpage>&#8211;<lpage>518</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-0691.2006.01408.x</pub-id>
<?supplied-pmid 16700698?><pub-id pub-id-type="pmid">16700698</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singhai</surname><given-names>N.</given-names></name><name><surname>Kumar</surname><given-names>M.</given-names></name><name><surname>Kanaujia</surname><given-names>P.</given-names></name><name><surname>Virdi</surname><given-names>J. S.</given-names></name></person-group> (<year>2015</year>). <article-title>MALDI-TOF massspectrometry: an emerging technology for microbial identification and diagnosis.</article-title>
<source><italic>Front. Microbiol.</italic></source>
<volume>6</volume>:<issue>791</issue>
<pub-id pub-id-type="doi">10.3389/fmicb.2015.00791</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumitomo</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>Y.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Honda-Ogawa</surname><given-names>M.</given-names></name><name><surname>Nakagawa</surname><given-names>S.</given-names></name><name><surname>Yamaguchi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Streptococcal cysteine protease-mediated cleavage of desmogleins is involved in the pathogenesis of cutaneous infection.</article-title>
<source><italic>Front. Cell. Infect. Microbiol.</italic></source>
<volume>8</volume>:<issue>10</issue>. <pub-id pub-id-type="doi">10.3389/fcimb.2018.00010</pub-id>
<?supplied-pmid 29416987?><pub-id pub-id-type="pmid">29416987</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumitomo</surname><given-names>T.</given-names></name><name><surname>Nakata</surname><given-names>M.</given-names></name><name><surname>Higashino</surname><given-names>M.</given-names></name><name><surname>Terao</surname><given-names>Y.</given-names></name><name><surname>Kawabata</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Group a Streptococcal cysteine protease cleaves epithelial junctions and contributes to bacterial translocation.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>288</volume>
<fpage>13317</fpage>&#8211;<lpage>13324</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.459875</pub-id>
<?supplied-pmid 23532847?><pub-id pub-id-type="pmid">23532847</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terao</surname><given-names>Y.</given-names></name><name><surname>Mori</surname><given-names>Y.</given-names></name><name><surname>Yamaguchi</surname><given-names>M.</given-names></name><name><surname>Shimizu</surname><given-names>Y.</given-names></name><name><surname>Ooe</surname><given-names>K.</given-names></name><name><surname>Hamada</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>283</volume>
<fpage>6253</fpage>&#8211;<lpage>6260</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M704821200</pub-id>
<?supplied-pmid 18160402?><pub-id pub-id-type="pmid">18160402</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van</surname><given-names>T. T.</given-names></name><name><surname>Chin</surname><given-names>J.</given-names></name><name><surname>Chapman</surname><given-names>T.</given-names></name><name><surname>Tran</surname><given-names>L. T.</given-names></name><name><surname>Coloe</surname><given-names>P. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Safety of raw meat and shellfish in Vietnam: an analysis of <italic>Escherichia coli</italic> isolations for antibiotic resistance and virulence genes.</article-title>
<source><italic>Int. J. Food Microbiol.</italic></source>
<volume>124</volume>
<fpage>217</fpage>&#8211;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2008.03.029</pub-id>
<?supplied-pmid 18457892?><pub-id pub-id-type="pmid">18457892</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>M. J.</given-names></name><name><surname>Barnett</surname><given-names>T. C.</given-names></name><name><surname>McArthur</surname><given-names>J. D.</given-names></name><name><surname>Cole</surname><given-names>J. N.</given-names></name><name><surname>Gillen</surname><given-names>C. M.</given-names></name><name><surname>Henningham</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Disease manifestations and pathogenic mechanisms of Group A Streptococcus.</article-title>
<source><italic>Clin. Microbiol. Rev.</italic></source>
<volume>27</volume>
<fpage>264</fpage>&#8211;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00101-13</pub-id>
<?supplied-pmid 24696436?><pub-id pub-id-type="pmid">24696436</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>M. J.</given-names></name><name><surname>Hollands</surname><given-names>A.</given-names></name><name><surname>Sanderson-Smith</surname><given-names>M. L.</given-names></name><name><surname>Cole</surname><given-names>J. N.</given-names></name><name><surname>Kirk</surname><given-names>J. K.</given-names></name><name><surname>Henningham</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection.</article-title>
<source><italic>Nat. Med.</italic></source>
<volume>13</volume>
<fpage>981</fpage>&#8211;<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1038/nm1612</pub-id>
<?supplied-pmid 17632528?><pub-id pub-id-type="pmid">17632528</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallace</surname><given-names>A. C.</given-names></name><name><surname>Laskowski</surname><given-names>R. A.</given-names></name><name><surname>Thornton</surname><given-names>J. M.</given-names></name></person-group> (<year>1995</year>). <article-title>LIGPLOT: a program to generate schematics diagrams of protein-ligand interaction.</article-title>
<source><italic>Protein Eng.</italic></source>
<volume>8</volume>
<fpage>127</fpage>&#8211;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1093/protein/8.2.127</pub-id><pub-id pub-id-type="pmid">7630882</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiederstein</surname><given-names>M.</given-names></name><name><surname>Sippl</surname><given-names>M. J.</given-names></name></person-group> (<year>2007</year>). <article-title>ProSA &#8211; web interactive web service for the recognition of errors in three-dimensional structures of proteins.</article-title>
<source><italic>Nucleic Acids. Res.</italic></source>
<volume>35</volume>
<fpage>407</fpage>&#8211;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm290</pub-id>
<?supplied-pmid 17517781?><pub-id pub-id-type="pmid">17517781</pub-id></mixed-citation></ref></ref-list></back></article>